Latest filing published 29 Dec 2021 for Dicerna Pharmaceuticals Inc, €80k.
All filings by Bob D. Brown on record concern Dicerna Pharmaceuticals Inc, in the capacity of senior executive. We count 82 filings; the first trade dates from 9 May 2018 and the latest from 28 December 2021.
Sales make up the whole of the open-market record (40 sales, €7.7M). Other entries cover 2 share grants and 39 option exercises. So far in 2021, the count stands at no purchases and 21 sales.
On 29 December 2021 came the latest disclosure, a transaction for €80k in Dicerna Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 82 declarations